Prominent regression of corneal crystalline deposits in multiple myeloma after treatment with proteasome inhibitor

MeSH terms

• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bortezomib / administration & dosage
• Bortezomib / therapeutic use*
• Corneal Opacity / drug therapy*
• Corneal Opacity / etiology
• Crystallization
• Dexamethasone / administration & dosage
• Female
• Humans
• Multiple Myeloma / complications
• Multiple Myeloma / drug therapy*
• Proteasome Inhibitors / therapeutic use*